DOSE — Rapid Dose Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Rapid Dose Therapeutics, fiscal year end - February 28th, CAD millions except per share, conversion factor applied.

	2022 February 28th	2023 February 28th	2024 February 29th	2025 February 28th	2026 February 28th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.034	0.028	0.161	0.021	0.012
Net Total Accounts Receivable
Net Total Receivables	0.183	0.146	0.219	0.303	0.168
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.614	0.42	0.679	0.664	0.364
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.45	1.83	1.21	0.971	2.85
Other Long Term Assets
Total Assets	3.07	2.25	1.89	1.63	3.28
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.45	4.7	2.92	6.84	8.44
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	2.82	4.92	5.04	6.84	10.5
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.252	-2.67	-3.16	-5.21	-7.18
Total Liabilities & Shareholders' Equity	3.07	2.25	1.89	1.63	3.28
Total Common Shares Outstanding